These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1736938)

  • 1. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.
    Mbemba E; Carré V; Atemezem A; Saffar L; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1996 Jan; 12(1):47-53. PubMed ID: 8825618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody directed to sulfatide inhibits the binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein to macrophages but not their infection by the virus.
    Seddiki N; Ramdani A; Saffar L; Portoukalian J; Gluckman JC; Gattegno L
    Biochim Biophys Acta; 1994 Feb; 1225(3):289-96. PubMed ID: 8312376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal T cell receptor-mediated signaling in T cell lines stably expressing HIV-1 envelope glycoproteins.
    Tani Y; Tian H; Lane HC; Cohen DI
    J Immunol; 1993 Dec; 151(12):7337-48. PubMed ID: 7903106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction by human immunodeficiency viruses types 1 and 2 of degradation of CD4 but not of a CD4 mutant unable to bind viral envelope glycoproteins.
    Cucchiarini M; Cagnon L; Giordanengo V; Doglio A; Lefebvre JC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(5):427-36. PubMed ID: 7697438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
    Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
    Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein.
    Fenouillet E; Gluckman JC
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1919-26. PubMed ID: 1678778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1.
    Gattegno L; Sadeghi H; Saffar L; Bladier D; Clerget-Raslain B; Gluckman JC; Bahraoui E
    Carbohydr Res; 1991 Jun; 213():79-93. PubMed ID: 1682045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
    Haidar M; Seddiki N; Gluckman JC; Gattegno L
    Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.
    Seddiki N; Rabehi L; Benjouad A; Saffar L; Ferriere F; Gluckman JC; Gattegno L
    Glycobiology; 1997 Dec; 7(8):1229-36. PubMed ID: 9455924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4.
    Andersen O; Sørensen AM; Svehag SE; Fenouillet E
    Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.
    Rabehi L; Ferriere F; Saffar L; Gattegno L
    Glycoconj J; 1995 Feb; 12(1):7-16. PubMed ID: 7795416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable expression of the human immunodeficiency virus type 1 envelope glycoprotein in transfected L cells.
    Bird C; Gleeson PA; Ramsay A; Li P; McCluskey J
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):1999-2009. PubMed ID: 1493050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9.
    Chen YH; Ebenbichler C; Vornhagen R; Schulz TF; Steindl F; Böck G; Katinger H; Dierich MP
    AIDS; 1992 Jun; 6(6):533-9. PubMed ID: 1388873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
    Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
    AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1.
    Saifuddin M; Hart ML; Gewurz H; Zhang Y; Spear GT
    J Gen Virol; 2000 Apr; 81(Pt 4):949-55. PubMed ID: 10725420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
    Ashorn P; Berger EA; Moss B
    Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.